IART (Integra Lifesciences Holdings) Marketable Securities: $60 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IART Integra Lifesciences Holdings Corp IART
71 GF Score
Price $17.24
GF Value $20.57
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Integra Lifesciences Holdings Marketable Securities?

Integra Lifesciences Holdings IART +0.94% 71 Marketable Securities is $60 Mil as of Jun. 2026. GuruFocus rates IART with a GF Score™ of 71/100 and a GF Value™ of $20.57 (Modestly Undervalued). The stock has 8 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Integra Lifesciences Holdings's Marketable Securities for the quarter that ended in Jun. 2026 was $60 Mil.

Integra Lifesciences Holdings's annual Marketable Securities declined from Dec. 2023 ($33 Mil) to Dec. 2024 ($27 Mil) but then increased from Dec. 2024 ($27 Mil) to Dec. 2025 ($29 Mil).

Integra Lifesciences Holdings  (NAS:IART) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Integra Lifesciences Holdings Marketable Securities Related Terms

Integra Lifesciences Holdings Marketable Securities Historical Data

* Premium members only.

The historical data trend for Integra Lifesciences Holdings's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integra Lifesciences Holdings Marketable Securities Chart

Integra Lifesciences Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 32.69 27.19 28.69

Integra Lifesciences Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.69 35.69 28.69 28.69 59.67
IART
71GF Score
Integra Lifesciences Holdings Corp IART
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Integra Lifesciences Holdings Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $60 Mil mean?
Integra Lifesciences Holdings (IART) has a Marketable Securities of $60 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Integra Lifesciences Holdings and its competitors.
Is Integra Lifesciences Holdings' Marketable Securities too high?
Integra Lifesciences Holdings' current Marketable Securities is $60 Mil. Overall, Integra Lifesciences Holdings has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Integra Lifesciences Holdings' Marketable Securities compare to ENOV and AHCO?
Integra Lifesciences Holdings' Marketable Securities of $60 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Integra Lifesciences Holdings and its competitors. Integra Lifesciences Holdings's current Marketable Securities is $60 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integra Lifesciences Holdings stock overvalued right now?
Based on GuruFocus' analysis, Integra Lifesciences Holdings (IART) is currently considered Modestly Undervalued. The stock's GF Value™ is $20.57, compared to a current price of $17.24 — trading 16.2% below its estimated fair value. The current Marketable Securities is $60 Mil. Integra Lifesciences Holdings' overall GF Score™ is 71/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Integra Lifesciences Holdings (IART), the current Marketable Securities is $60 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Integra Lifesciences Holdings (IART) Overvalued in 2026?

Based on GuruFocus' analysis, Integra Lifesciences Holdings stock appears to be undervalued. The current stock price of $17.24 is trading 16.2% below its estimated GF Value™ of $20.57. GuruFocus considers Integra Lifesciences Holdings to be Modestly Undervalued.

Key valuation signals for IART:

  • Marketable Securities: $60 Mil
  • GF Value™: $20.57 vs. price of $17.24 (16.2% below fair value)
  • GF Score™: 71/100 with 8 warning signs

No single metric tells the full story. See the IART stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Integra Lifesciences Holdings Business Description

Other Exchanges IL3:Germany
Address 1100 Campus Road, Princeton, NJ, USA, 08540
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
71GF Score

Get the complete analysis for IART

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.24
Price
$20.57
GF Value